argenx Announces Positive Topline Results from Phase 3 ALKIVIA Trial of Efgartigimod in Autoimmune Myositis
Stocks in this Quantisnow insightHealth Care
Quantisnow market dataNASDAQ
ARGX
argenx SE
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2017
Get push alerts for ARGX
Full ARGX profile on Quantisnow Follow ARGX and get a push notification the moment its next story breaks.